Pesquise e encontre o CMO / CDMO de que precisa

TAMANHO DO LOTE: Medium, Large

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS, SERVIÇOS, ENGENHARIA DE PARTÍCULAS, QUÍMICO-SINTÉTICO

CONFORMIDADE: Roszdravnadzor (Russia GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP), ICH

SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

MERCADOS: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada)

USAR: Human

SERVIÇOS: Analytical / QC services, Manufacturing services, Packaging, Quality Assurance services

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

REGIÃO: América do Norte

TAMANHO DO LOTE: Small, Medium, Large

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS, SERVIÇOS, ENGENHARIA DE PARTÍCULAS, QUÍMICO-SINTÉTICO

CONFORMIDADE: Roszdravnadzor (Russia GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP), ICH

SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

MERCADOS: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada), MHRA (UK)

USAR: Human

SERVIÇOS: Analytical / QC services, Manufacturing services, Development services, Packaging, Quality Assurance services

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

REGIÃO: América do Norte

TAMANHO DO LOTE: Small, Medium, Large

CONFORMIDADE: EMA (EU GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORIA / PRODUTO: SERVIÇOS, ENGENHARIA DE PARTÍCULAS, NUTRACÊUTICOS

REGIÃO: Europa

USAR: Human, Veterinary

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

SERVIÇOS: Manufacturing services, Development services

MERCADOS: FDA (USA), EMA (EU)

BSL (Nível de Segurança Biológica): 1, 2